SCHEMBL44143

SCHEMBL44143

CC(C)(C)OC(=O)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6116105 1.00
Hydrochloric Acid SCHEMBL336665 0.97 KDM4E (0.38)
Ammonia Solution, Strong SCHEMBL20241550 0.97 TDP1 (0.36)
SCHEMBL28278850 0.97 TDP1 (0.36)
Hydrochloric Acid SCHEMBL14659623 0.95 TDP1 (0.35)
Ethylamine SCHEMBL7474222 0.95 TDP1 (0.35)
Acetic Acid SCHEMBL4576890 0.93 GLRA1 (0.35)
SCHEMBL9725893 0.93 TDP1 (0.34)
Acetic Acid SCHEMBL23783571 0.91 KDM4E (0.37)
SCHEMBL22129127 0.91 HDAC1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6688 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119614203-B Etching solution for selectively etching silicon nitride and silicon oxide and titanium nitride 湖北兴福电子材料股份有限公司 2026-05-12 CN claimed
EP-4227300-B1 TRUNCATED EVANS BLUE MODIFIED FIBROBLAST ACTIVATION PROTEIN INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF YANTAI LANNACHENG BIOTECHNOLOGY CO LTD (CN) 2026-01-28 EP claimed
EP-4648766-A1 PI3K INHIBITORS AND METHODS OF MAKING AND USING THE SAME Relay Therapeutics, Inc. (US) 2025-11-19 EP claimed
CN-119528812-B Double amino acid-genipin derivative and preparation method and application thereof 广东工业大学 2025-06-03 CN claimed
CN-116836188-B Probe prodrug and probe for detecting OX-LDL and application of probe for detecting vascular atherosclerosis 南京大学 2025-05-06 CN claimed
US-20250135043-A1 DUAL-TARGETING COMPOUND FOR FIBROBLAST ACTIVATION PROTEIN (FAP) AND INTEGRIN avB3, PREPARATION METHOD THEREFOR AND USE THEREOF YANTAI LANNACHENG BIOTECHNOLOGY CO., LTD. (CN) 2025-05-01 US claimed
CN-115521328-B Organic boron fluorescent material and preparation method and application thereof 河南农业大学 2025-03-21 CN claimed
CN-119614203-A Etching solution for selectively etching silicon nitride and silicon oxide and titanium nitride 湖北兴福电子材料股份有限公司 2025-03-14 CN claimed
CN-119528812-A Double amino acid-genipin derivative and preparation method and application thereof 广东工业大学 2025-02-28 CN claimed
CN-119470406-A Phthalic dicarboxaldehyde disinfectant concentration detection test paper and preparation method thereof 山东新华莎罗雅生物技术有限公司 2025-02-18 CN claimed
US-5644059-A REACTION OF KETONE WITH ACRYLAMIDE AND AMMONIA OR AMMONIUM SALT FUJIREBIO INC. (JP) 1997-07-01 US claimed
US-5614522-A SULFONAMIDE AND UREA-CONTAINING HYDROXYETHYLAMINE COMPOUNDS G.D. SEARLE & CO. (US) 1997-03-25 US claimed
EP-0671911-A4 CARBOXY-PEPTIDYL DERIVATIVES AS ANTIDEGENERATIVE ACTIVE AGENTS. MERCK & CO INC (US) 1996-08-21 EP claimed
US-5492905-A NERVOUS SYSTEM DISORDERS ZENECA LIMITED (GB) 1996-02-20 US claimed
EP-0671911-A1 CARBOXY-PEPTIDYL DERIVATIVES AS ANTIDEGENERATIVE ACTIVE AGENTS MERCK & CO. INC. (US) 1995-09-20 EP claimed
WO-1994012169-A1 CARBOXY-PEPTIDYL DERIVATIVES AS ANTIDEGENERATIVE ACTIVE AGENTS MERCK & CO., INC. (US) 1994-06-09 WO claimed
WO-1993025534-A1 2,5-DIOXO-2,5-DIHYDRO-1H-BENZ[b]AZEPINES AS NMDA RECEPTOR ANTAGONISTS ZENECA LIMITED (GB) 1993-12-23 WO claimed
EP-0488345-A1 1,4-Dihydropyridine derivatives and methods of producing the same FUJIREBIO INC. (JP) 1992-06-03 EP claimed
US-4960881-A REACTING AMINO ACID WITH ALPHA-CHLORINATED CARBONATE IN SOLVENT IN PRESENCE OF ACID SCAVENGER SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) 1990-10-02 US claimed
US-4308168-A ALKYLESTERS OF AMINO ACIDS, NONTOXIC IDEMITSU KOSAN CO., LTD. (JP) 1981-12-29 US claimed